Literature DB >> 2857169

Purification and properties of H+-translocating, Mg2+-adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae.

E Uchida, Y Ohsumi, Y Anraku.   

Abstract

H+-translocating, Mg2+-ATPase was solubilized from vacuolar membranes of Saccharomyces cerevisiae with the zwitterionic detergent N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate and purified by glycerol density gradient centrifugation. Partially purified vacuolar membrane H+-ATPase, which had a specific activity of 18 units/mg of protein, was separated almost completely from acid phosphatase and alkaline phosphatase. The purified enzyme required phospholipids for maximal activity and hydrolyzed ATP, GTP, UTP, and CTP, with this order of preference. Its Km value for Mg2+-ATP was determined to be 0.21 mM and its optimal pH was 6.9. ADP inhibited the enzyme activity competitively, with a Ki value of 0.31 mM. The activity of purified ATPase was strongly inhibited by N,N'-dicyclohexylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, tributyltin, 7-chloro-4-nitrobenzoxazole, diethylstilbestrol, and quercetin, but was not affected by oligomycin, sodium azide, sodium vanadate, or miconazole. It was not inhibited at all by antiserum against mitochondrial F1-ATPase or mitochondrial F1-ATPase inhibitor protein. These results indicated that vacuolar membrane H+-ATPase is different from either yeast plasma membrane H+-ATPase or mitochondrial F1-ATPase. The vacuolar membrane H+-ATPase was found to be composed of two major polypeptides a and b of Mr = 89,000 and 64,000, respectively, and a N,N'-dicyclohexylcarbodiimide binding polypeptide c of Mr = 19,500, whose polypeptide composition was also different from those of either plasma membrane H+-ATPase or mitochondrial F1-ATPase of S. cerevisiae.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857169

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

Review 1.  A journey from mammals to yeast with vacuolar H+-ATPase (V-ATPase).

Authors:  Nathan Nelson
Journal:  J Bioenerg Biomembr       Date:  2003-08       Impact factor: 2.945

Review 2.  Subunit composition, biosynthesis, and assembly of the yeast vacuolar proton-translocating ATPase.

Authors:  P M Kane; T H Stevens
Journal:  J Bioenerg Biomembr       Date:  1992-08       Impact factor: 2.945

Review 3.  The fungal vacuole: composition, function, and biogenesis.

Authors:  D J Klionsky; P K Herman; S D Emr
Journal:  Microbiol Rev       Date:  1990-09

4.  Regulation of vacuolar proton-translocating ATPase activity and assembly by extracellular pH.

Authors:  Theodore T Diakov; Patricia M Kane
Journal:  J Biol Chem       Date:  2010-05-28       Impact factor: 5.157

5.  Definition of membrane topology and identification of residues important for transport in subunit a of the vacuolar ATPase.

Authors:  Masashi Toei; Satoko Toei; Michael Forgac
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

6.  Structure, Function, and Evolution of Proton-ATPases.

Authors:  N Nelson
Journal:  Plant Physiol       Date:  1988-01       Impact factor: 8.340

7.  Mechanism of the Decline in Vacuolar H -ATPase Activity in Mung Bean Hypocotyls during Chilling.

Authors:  C Matsuura-Endo; M Maeshima; S Yoshida
Journal:  Plant Physiol       Date:  1992-10       Impact factor: 8.340

8.  Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector.

Authors:  Neil Dixon; Tibor Páli; Terence P Kee; Stephen Ball; Michael A Harrison; John B C Findlay; Jonas Nyman; Kalervo Väänänen; Malcolm E Finbow; Derek Marsh
Journal:  Biophys J       Date:  2007-09-14       Impact factor: 4.033

9.  A yeast manganese transporter related to the macrophage protein involved in conferring resistance to mycobacteria.

Authors:  F Supek; L Supekova; H Nelson; N Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Bafilomycin L, a new inhibitor of cholesteryl ester synthesis in mammalian cells, produced by marine-derived Streptomyces sp. OPMA00072.

Authors:  Keisuke Kobayashi; Takashi Fukuda; Takeo Usui; Yuko Kurihara; Akihiko Kanamoto; Hiroshi Tomoda
Journal:  J Antibiot (Tokyo)       Date:  2014-08-06       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.